Seres Health to Present at 21st Annual BioCentury Future Leaders in the Biotech Industry Conference

Seres Health to Present at 21st Annual BioCentury Future Leaders in the Biotech Industry Conference

March 25, 2014

CAMBRIDGE, Mass., March 25, 2014 /PRNewswire/ -- Seres Health, a clinical-stage therapeutics company developing novel products to treat a host of disease conditions based on scientific findings related to the human microbiome, today announced that CEO and Co-founder Dr. David Berry will present a company overview at the 21st annual BioCentury Future Leaders in the Biotech Industry Conference.

Dr. Berry's presentation will focus on Seres' development of the first therapeutics that can catalyze a shift to health by augmenting the biology of the microbiome for the treatment of infectious, metabolic, and inflammatory diseases.

The presentation will take place on Friday, March 28, 2014 at 3:50 p.m. ET in presentation room 508 at the Millennium Broadway Hotel in New York City.

For more information on Seres Health please visit www.sereshealth.com

About Seres Health 

Seres Health is a clinical stage biotherapeutic company focused on discovering and developing Ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome.  Founded by Flagship VentureLabs, Seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome.  Current candidates span infectious, metabolic, and inflammatory diseases.  For more information, please visit www.sereshealth.com.

Contact:

For Seres Health            
Emily Rossi
Ruder Finn 
212.593.6431
flagship@ruderfinn.com

 

SOURCE Seres Health